CLINICAL TRIALS PROFILE FOR WESTCORT
✉ Email this page to a colleague
All Clinical Trials for WESTCORT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00186628 ↗ | Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD | Completed | National Cancer Institute (NCI) | Phase 2 | 2005-06-01 | To determine if rituximab administered after allogeneic transplantation decreases the incidence of chronic graft-vs-host disease (cGvHD) |
NCT00186628 ↗ | Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD | Completed | The Leukemia and Lymphoma Society | Phase 2 | 2005-06-01 | To determine if rituximab administered after allogeneic transplantation decreases the incidence of chronic graft-vs-host disease (cGvHD) |
NCT00186628 ↗ | Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD | Completed | Stanford University | Phase 2 | 2005-06-01 | To determine if rituximab administered after allogeneic transplantation decreases the incidence of chronic graft-vs-host disease (cGvHD) |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for WESTCORT
Condition Name
Clinical Trial Locations for WESTCORT
Trials by Country
Clinical Trial Progress for WESTCORT
Clinical Trial Phase
Clinical Trial Sponsors for WESTCORT
Sponsor Name